SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001104659-12-049611
Filing Date
2012-07-18
Accepted
2012-07-18 17:15:12
Documents
2
Group Members
DAVID H. BATCHELDERRALPH V. WHITWORTHRELATIONAL INVESTORS MID-CAP FUND I, L.P.RELATIONAL INVESTORS MID-CAP FUND II, L.P.

Document Format Files

Seq Description Document Type Size
1 SC 13D/A a12-16567_1sc13da.htm SC 13D/A 133490
2 EXHIBIT A a12-16567_1ex99da.htm EX-99.A 76278
  Complete submission text file 0001104659-12-049611.txt   211563
Mailing Address 300 TICE BOULEVARD WOODCLIFF LAKE NJ 07677
Business Address 300 TICE BOULEVARD WOODCLIFF LAKE NJ 07677 201-802-4000
PAR PHARMACEUTICAL COMPANIES, INC. (Subject) CIK: 0000878088 (see all company filings)

IRS No.: 223122182 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-46121 | Film No.: 12968527
SIC: 2834 Pharmaceutical Preparations

Mailing Address 12400 HIGH BLUFF DRIVE SUITE 600 SAN DIEGO CA 92130
Business Address 12400 HIGH BLUFF DRIVE SUITE 600 SAN DIEGO CA 92130 858.704.3333
RELATIONAL INVESTORS LLC (Filed by) CIK: 0001047644 (see all company filings)

IRS No.: 330694767 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A